Epigenetic Regulation of Cancer in Response to Chemotherapy

Erscheinungsjahr 2023
ISBN: 978-0-443-19418-4
Verlag: Elsevier Science & Technology

Buch, Englisch, 312 Seiten, Format (B × H): 151 mm x 229 mm, Gewicht: 840 g

Epigenetic Regulation of Cancer in Response to Chemotherapy, Volume 158 of the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting chapters on timely topics, including Epigenetically Programmed Resistance to Chemotherapy and Promotion of Immune Evasion in Cancer, A Role for the Epigenome in Cancer Cell Drug Tolerance, Histone Methylation and X Chromosomal Genes in Metastasis of Breast Cancer, Targeting Epigenetic Regulation Using Small Molecule Inhibitors, Histone Deacetylase Inhibitors as Sanguine Epigenetic Therapeutics against Pugnacious Lung Cancer, From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia), and more.

Additional chapters cover Predictive Models of Chemoresistance Generated by Crunching the Public Drug Screen, Epigenomic and Genomic Profiling Datasets via Regression-, Machine Learning, and Knowledge-Based Methods, Probing on the Mechanisms of lncRNAs on Cancer Drug Resistance, Drug Tolerant Persister Cells in Cancer: Current Knowledge and Therapeutic Perspectives, and much more.

Zielgruppe

Researchers and students

Autoren/Hrsg.

Weitere Mitwirkende

Landry, Joseph

Das, Swadesh

Fachgebiete

• Naturwissenschaften Biowissenschaften Zellbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
• Naturwissenschaften Biowissenschaften Mikrobiologie
• Naturwissenschaften Biowissenschaften Biowissenschaften Genetik und Genomik (nichtmedizinisch)

Inhaltsverzeichnis

1. Epigenetically Programmed Resistance to Chemotherapy and Promotion of Immune Evasion in CancerKatherine Chiappinelli2. A Role for the Epigenome in Cancer Cell Drug ToleranceMarie Classon3. Histone Methylation and X Chromosomal Genes in Metastasis of Breast CancerFei Chen4. Targeting Epigenetic Regulation Using Small Molecule InhibitorsPaul B. Fisher5. Histone Deacetylase Inhibitors as Sanguine Epigenetic Therapeutics against Pugnacious Lung CancerShabir Ahmad Ganai6. From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia)Wei-Jun Yang and Chris Wood7. Predictive Models of Chemoresistance Generated by Crunching the Public Drug Screen, Epigenomic and Genomic Profiling Datasets via Regression-, Machine Learning-, and Knowledge-Based MethodsManny Bacolod8. Probing on the Mechanisms of lncRNAs on Cancer Drug ResistanceChandrima Das9. Drug Tolerant Persister Cells in Cancer: Current Knowledge and Therapeutic PerspectivesXia Weiwei10. Epigenetic Adaptations in Drug-Tolerant Tumor CellsShibasish Chowdhury11. A Role for Epigenetics in the Recovery from Chemotherapy ExposureJoseph Landry12. Reprogramming the Cancer Epigenome - Synergistic Therapy with Epigenetic DrugsVijayalakshmi Mahadevan13. Targeting the Super Elongation Complex for Oncogenic Transcription Driven Tumor Malignancies: Progress in Structure, Mechanisms and Small Molecular Inhibitor DiscoveryKehao Zhao

Über Autor(innen)

Landry, Joseph
Joseph Landry works at Institute of Molecular Medicine, Virginia Commonwealth University, Richmond, VA, USA.

Das, Swadesh
Dr. Swadesh Das works at Massey Cancer Center, Richmond, Virginia, USA.